New Biomarkers of Coffee Consumption Identified by the Non-Targeted Metabolomic Profiling of Cohort Study Subjects

被引:96
作者
Rothwell, Joseph A. [1 ,2 ]
Fillatre, Yoann [1 ,2 ]
Martin, Jean-Francois [1 ,3 ]
Lyan, Bernard [1 ,3 ]
Pujos-Guillot, Estelle [1 ,3 ]
Fezeu, Leopold [4 ]
Hercberg, Serge [4 ]
Comte, Blandine [1 ,2 ]
Galan, Pilar [4 ]
Touvier, Mathilde [4 ]
Manach, Claudine [1 ,2 ]
机构
[1] INRA, CRNH Auvergne, Human Nutr Unit, UMR 1019, Clermont Ferrand, France
[2] Clermont Univ, Human Nutr Unit, Clermont Ferrand, France
[3] INRA, Clermont Ferrand, France
[4] Univ Paris 07, Univ Paris 05,CNAM, Epidemiol & Biostat Res Ctr,INSERM U1153,INRA U11, Nutrit Epidemiol Res Team,Univ Paris 13,Sorbonne, Bobigny, France
关键词
MASS-SPECTROMETRY; CARDIOVASCULAR-DISEASE; CAFFEINE; RISK; DISCOVERY; HEALTH; METAANALYSIS; FLAVONOIDS; CAFESTOL; KAHWEOL;
D O I
10.1371/journal.pone.0093474
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Coffee contains various bioactives implicated with human health and disease risk. To accurately assess the effects of overall consumption upon health and disease, individual intake must be measured in large epidemiological studies. Metabolomics has emerged as a powerful approach to discover biomarkers of intake for a large range of foods. Here we report the profiling of the urinary metabolome of cohort study subjects to search for new biomarkers of coffee intake. Using repeated 24-hour dietary records and a food frequency questionnaire, 20 high coffee consumers (183-540 mL/d) and 19 low consumers were selected from the French SU.VI.MAX2 cohort. Morning spot urine samples from each subject were profiled by high-resolution mass spectrometry. Partial least-square discriminant analysis of multidimensional liquid chromatography-mass spectrometry data clearly distinguished high consumers from low via 132 significant (p-value<0.05) discriminating features. Ion clusters whose intensities were most elevated in the high consumers were annotated using online and in-house databases and their identities checked using commercial standards and MS-MS fragmentation. The best discriminants, and thus potential markers of coffee consumption, were the glucuronide of the diterpenoid atractyligenin, the diketopiperazine cyclo(isoleucyl-prolyl), and the alkaloid trigonelline. Some caffeine metabolites, such as 1-methylxanthine, were also among the discriminants, however caffeine may be consumed from other sources and its metabolism is subject to inter-individual variation. Receiver operating characteristics curve analysis showed that the biomarkers identified could be used effectively in combination for increased sensitivity and specificity. Once validated in other cohorts or intervention studies, these specific single or combined biomarkers will become a valuable alternative to assessment of coffee intake by dietary survey and finally lead to a better understanding of the health implications of coffee consumption.
引用
收藏
页数:11
相关论文
共 43 条
[1]  
Al-Habori M, 1998, PHYTOTHER RES, V12, P233, DOI 10.1002/(SICI)1099-1573(199806)12:4<233::AID-PTR294>3.0.CO
[2]  
2-V
[3]  
[Anonymous], 2006, BRIT J NUTR, DOI DOI 10.1079/BJN20061808
[4]   CONTROLLING THE FALSE DISCOVERY RATE - A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING [J].
BENJAMINI, Y ;
HOCHBERG, Y .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1995, 57 (01) :289-300
[5]   THE ABSOLUTE BIOAVAILABILITY OF CAFFEINE IN MAN [J].
BLANCHARD, J ;
SAWERS, SJA .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 24 (01) :93-98
[6]   Effects of tea and coffee on cardiovascular disease risk [J].
Bohn, Siv K. ;
Ward, Natalie C. ;
Hodgson, Jonathan M. ;
Croft, Kevin D. .
FOOD & FUNCTION, 2012, 3 (06) :575-591
[7]   Long-term antioxidant supplementation has no effect on health-related quality of life: The randomized, double-blind, placebo-controlled, primary prevention SU.VI.MAX trial [J].
Briancon, Serge ;
Boini, Stephanie ;
Bertrais, Sandrine ;
Guillemin, Francis ;
Galan, Pilar ;
Hercberg, Serge .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2011, 40 (06) :1605-1616
[8]   Coffee and its Consumption: Benefits and Risks [J].
Butt, Masood Sadiq ;
Sultan, M. Tauseef .
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2011, 51 (04) :363-373
[9]   Coffee, caffeine, and coronary heart disease [J].
Cornelis, Marilyn C. ;
El-Sohemy, Ahmed .
CURRENT OPINION IN LIPIDOLOGY, 2007, 18 (01) :13-19
[10]   Coffee acutely increases sympathetic nerve activity and blood pressure independently of caffeine content -: Role of habitual versus nonhabitual drinking [J].
Corti, R ;
Binggeli, C ;
Sudano, I ;
Spieker, L ;
Hänseler, E ;
Ruschitzka, F ;
Chaplin, WF ;
Lüscher, TF ;
Noll, G .
CIRCULATION, 2002, 106 (23) :2935-2940